Up Is Down - Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval.

Avorn, Jerry; Kesselheim, Aaron S

Avorn, Jerry; Kesselheim, Aaron S.

Afiliación

Avorn J; From the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School - both in Boston.
Kesselheim AS; From the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School - both in Boston.

N Engl J Med ; 383(18): 1706-1708, 2020 Oct 29.

Article en En | MEDLINE | ID: mdl-32931162

Asunto(s)

Infecciones por Coronavirus/prevención & control; Aprobación de Drogas; Industria Farmacéutica/tendencias; Pandemias/prevención & control; Neumonía Viral/prevención & control; Vacunas Virales/normas; Betacoronavirus; COVID-19; Vacunas contra la COVID-19; Humanos; Política; SARS-CoV-2; Estados Unidos; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neumonía Viral / Vacunas Virales / Aprobación de Drogas / Infecciones por Coronavirus / Industria Farmacéutica / Pandemias Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: N Engl J Med Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google